Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bruun Madsen

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
BMJ Open|February 22, 2023
Hyperbaric oxygen treatment in the management of necrotising soft-tissue infections: results from a Danish nationwide registry studyMorten Hedetoft, Martin Bruun Madsen, Ole Hyldegaard
Advances in Experimental Medicine and Biology|October 20, 2020
Necrotizing Soft-Tissue Infections: Clinical Features and Diagnostic AspectsMartin Bruun Madsen, Per Arnell, Ole Hyldegaard
Intensive Care Medicine|May 13, 2020
Understanding necrotizing soft tissue infections in the intensive care unitTomas Urbina, Martin Bruun Madsen, Nicolas de Prost
Advances in Experimental Medicine and Biology|October 20, 2020
Treatment of Necrotizing Soft Tissue Infections: IVIGMartin Bruun Madsen, Helena Bergsten, Anna Norrby-Teglund
Physiological Reports|March 15, 2021
Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infectionMorten Hedetoft, Peter Garred, Martin Bruun Madsen, et al.
Intensive Care Medicine|January 20, 2018
Immunoglobulins and sepsisManu Shankar-Hari, Martin Bruun Madsen, Alexis F Turgeon
BMJ Open|October 17, 2020
Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005-2018: a Danish nationwide register-based cohort studyMorten Hedetoft, Martin Bruun Madsen, Lærke Bruun Madsen, et al.
Danish Medical Journal|July 12, 2016
Immunoglobulin for necrotising soft tissue infections (INSTINCT): protocol for a randomised trialMartin Bruun Madsen, Theis Lange, Peter Buhl Hjortrup, et al.
Journal of Innate Immunity|December 14, 2021
Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue InfectionMorten Hedetoft, Martin Bruun Madsen, Cecilie Bo Hansen, et al.
BMC Infectious Diseases|October 10, 2021
Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infectionMorten Hedetoft, Marco Bo Hansen, Martin Bruun Madsen, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
BMJ Open|February 22, 2023
Hyperbaric oxygen treatment in the management of necrotising soft-tissue infections: results from a Danish nationwide registry studyMorten Hedetoft, Martin Bruun Madsen, Ole Hyldegaard
Advances in Experimental Medicine and Biology|October 20, 2020
Necrotizing Soft-Tissue Infections: Clinical Features and Diagnostic AspectsMartin Bruun Madsen, Per Arnell, Ole Hyldegaard
Intensive Care Medicine|May 13, 2020
Understanding necrotizing soft tissue infections in the intensive care unitTomas Urbina, Martin Bruun Madsen, Nicolas de Prost
Advances in Experimental Medicine and Biology|October 20, 2020
Treatment of Necrotizing Soft Tissue Infections: IVIGMartin Bruun Madsen, Helena Bergsten, Anna Norrby-Teglund
Physiological Reports|March 15, 2021
Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infectionMorten Hedetoft, Peter Garred, Martin Bruun Madsen, et al.
Intensive Care Medicine|January 20, 2018
Immunoglobulins and sepsisManu Shankar-Hari, Martin Bruun Madsen, Alexis F Turgeon
BMJ Open|October 17, 2020
Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005-2018: a Danish nationwide register-based cohort studyMorten Hedetoft, Martin Bruun Madsen, Lærke Bruun Madsen, et al.
Danish Medical Journal|July 12, 2016
Immunoglobulin for necrotising soft tissue infections (INSTINCT): protocol for a randomised trialMartin Bruun Madsen, Theis Lange, Peter Buhl Hjortrup, et al.
Journal of Innate Immunity|December 14, 2021
Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue InfectionMorten Hedetoft, Martin Bruun Madsen, Cecilie Bo Hansen, et al.
BMC Infectious Diseases|October 10, 2021
Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infectionMorten Hedetoft, Marco Bo Hansen, Martin Bruun Madsen, et al.
Pageof 3